Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Syra Health Corp. Class A (SYRA) Stock Price & Analysis

SYRA Stock Chart & Stats

$0.92$0.02(2.22%)
At close: 11:03 AM EST
$0.7$0.8$0.9$110 Aug24 Aug8 Sep21 Sep5 Oct19 Oct2 Nov
Day’s Range
$0.90 - $0.94
52-Week Range
$0.06 - $1.15
Previous Close
$0.90
Volume
N/A
Average Volume (3M)
14.77K
Market Cap
$12.78M
Enterprise Value
$6.66M
Total Cash (Recent Filing)
$2.12M
Total Debt (Recent Filing)
$149.34K
Price to Earnings (P/E)
103.3
Beta
1.45
Next Earnings
Mar 17, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue And Profitability Turnaround

The sharp TTM revenue increase and return to profitability indicate meaningful operating improvement and stronger market traction. If this progress persists, expanding revenue can provide a broader base for fixed-cost absorption, reinvestment, and more durable earnings over the next several quarters.

Conservative Current Leverage

Low current leverage gives Syra greater financial flexibility while it scales its healthcare services and technology offerings. A stronger equity position and expanding asset base can reduce balance-sheet pressure, support continued investment, and improve resilience if operating conditions become less favorable.

Improving Gross Margin And Cash Generation

Improved gross margin suggests better unit economics, while positive operating and free cash flow provide early evidence that reported growth is beginning to translate into internally generated funds. Continued conversion would strengthen self-funding capacity and reduce reliance on external capital.

Bears Say

Thin Operating Profitability

Very narrow margins leave limited room for cost increases, execution setbacks, or slower revenue growth before earnings are pressured. Although the company has returned to profit, the small cushion means profitability may remain fragile until scale and improved unit economics produce more consistent operating leverage.

Cash Flow Durability Remains Unproven

The move to positive cash generation is encouraging, but its modest size and history of substantial cash burn do not yet demonstrate a stable funding engine. Weak durability could constrain growth investments or make the company more dependent on financing if profitability fails to improve consistently.

Recent Balance-sheet Strength Has A Volatile History

Historical negative equity and elevated leverage show that Syra has previously experienced significant capitalization stress. Even with conservative current leverage, that record raises questions about the durability of the rebound and highlights the need for sustained profits and cash generation to preserve financial stability.

Syra Health Corp. Class A News

SYRA FAQ

What was Syra Health Corp. Class A’s price range in the past 12 months?
Syra Health Corp. Class A lowest stock price was $0.06 and its highest was $1.15 in the past 12 months.
What is Syra Health Corp. Class A’s market cap?
Syra Health Corp. Class A’s market cap is $12.78M.
When is Syra Health Corp. Class A’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Syra Health Corp. Class A’s earnings last quarter?
Syra Health Corp. Class A released its earnings results on Nov 03, 2026. The company reported $0.02 earnings per share for the quarter.
Is Syra Health Corp. Class A overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Syra Health Corp. Class A pay dividends?
Syra Health Corp. Class A does not currently pay dividends.
What is Syra Health Corp. Class A’s EPS estimate?
Syra Health Corp. Class A’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syra Health Corp. Class A have?
Syra Health Corp. Class A has 13,850,279 shares outstanding.
What happened to Syra Health Corp. Class A’s price movement after its last earnings report?
Syra Health Corp. Class A reported an EPS of $0.02 in its last earnings report. Following the earnings report the stock price went up 31.024%.
Which hedge fund is a major shareholder of Syra Health Corp. Class A?
Currently, no hedge funds are holding shares in SYRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology